Search results
Author(s):
Mandeep Mehra
,
Christian Inchaustegui
Added:
1 year ago
In 2023, we are excited to partner with @CardioNerds, a dynamic team dedicated to democratizing cardiovascular education. Experience a fresh perspective on the new data through an interview series featuring principal investigators and ambassadors from the CardioNerds family.These interviews are supported by an educational grant from Novo Nordisk Inc. This content is not intended for UK HCPs.
View more
Mauro Lencioni
Job title: Consultant Cardiologist & Electrophysiologist
Author
Author(s):
Added:
3 months ago
AHA Conference 2024 - Primary safety and efficacy results from ENDEAVOR investigating the effect of myeloperoxidase inhibition with mitiperstat (AstraZeneca) on symptoms and exercise capacity in patients with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF).Dr Sanjiv Shah (Bluhm Cardiovascular Institute, Chicago, US) joins us onsite at AHA Conference to discuss the…
View more
Angela Maas
Author
Simon Wilson
Job title: Interventional Cardiologist
Author
Author(s):
Harriette Van Spall
,
Gregg Stone
Added:
11 months ago
ACC 2024 — Late-breaker host Dr Harriette Van Spall (McMaster University, CA) welcomes Principal Investigator Dr Gregg Stone (Icahn School of Medicine at Mount Sinai, New York, NY, US) to discuss the REducing Lung congestIon Symptoms Using the v-wavE Shunt in adVancEd Heart Failure (NCT03499236) (V-Wave Ltd).The RELIEVE-HF trial aims to assess the safety and efficacy of a new device, the V-Wave…
View more
Author(s):
Harriette Van Spall
,
Mikhail Kosiborod
Added:
1 year ago
ESC 2023 – Late-Breaker host, Dr Harriette Van Spall (McMaster University, CA) is joined by Dr Mikhail Kosiborod (Saint Luke’s Mid America Heart Institute, US) to discuss the findings from the STEP HFpEF trial (NCT04788511).
Around half of patients with heart failure have heart failure with preserved ejection fraction (HFpEF), and most patients with HFpEF are overweight or obese. Patients with…
View more
Kerry Skurka
Research Area(s) / Expertise:
Job title: Cardio-oncology Nurse
Author
Anecita P. Fadol
Research Area(s) / Expertise:
Job title: Department of Nursing, Division of SrVP and Chief Nursing Officer
Author
Author(s):
Firas Zahr
Added:
1 year ago
THT 24 - We are joined by Dr Firas Zahr (OHSU Knight Cardiovascular Institute Cardiology Clinic, US) to discuss the findings from the ALT FLOW Early Feasibility study (NCT03523416).The ALT FLOW Early Feasibility study aims to assess the initial clinical safety, functionality and effectiveness of a transcatheter atrial shunt system created by Edwards. 75 patients with symptomatic heart failure…
View more